Serum soluble tumor necrosis factor receptor levels in patients with seasonal allergic rhinitis

Kokuludaǧ A., Terzioǧlu E., KIRMAZ C., Sin A., Sebik F.

Journal of Investigational Allergology and Clinical Immunology, vol.11, no.1, pp.46-48, 2001 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 1
  • Publication Date: 2001
  • Journal Name: Journal of Investigational Allergology and Clinical Immunology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.46-48
  • Keywords: Allergic rhinitis, Eosinophil cationic protein, Seasonal rhinitis, Soluble tumor necrosis factor receptor
  • Manisa Celal Bayar University Affiliated: Yes

Abstract

It is known that several inflammatory cells and cytokines play a role in allergic inflammation. Furthermore, there are seasonal changes in several mediators responsible for allergic inflammation. The aim of this study was to determine seasonal changes in serum concentrations of soluble tumor necrosis factor receptors (sTNFRs) and the relationship with disease activity and other inflammation markers such as eosinophil cationic protein (ECP) in patients with seasonal allergic rhinitis. Serum levels of sTNFRI and sTNFRII were measured before and during the pollen season in 18 patients with seasonal allergic rhinitis and in 17 healthy controls by using commercially available enzyme-linked immunosorbent assay (ELISA) kits. The serum levels of sTNFRI, sTNTRII, IgE, and ECP were significantly higher in patients than those in controls before and during season, sTNFRI, sTNFRII, and IgE levels were higher before season, whereas ECP levels were higher during season. We suggest that sTNFRs might play regulatory roles even in early stages of allergic rhinitis when patients do not have clinical symptoms yet.